Investigation of Therapeutic Efficiency of Bleomycin and Bleomycin-Glucuronide Labeled with 131 I on the Cancer Cell Lines
- 1 May 2013
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 28 (4) , 310-319
Abstract
The aim of this study is to determine the incorporations of radiolabeled bleomycin (131I-BLM) and bleomycin-glucuronide (131I-BLMGLU) on PC-3 (human prostate carcinoma cell line), Caco-2 (human colon adenocarcinoma cell line), Hutu-80 (Human Duodenum adenocarcinoma cell line), and A549 (Human lung adenocarcinoma epithelial cell line) cancerous cell lines. For this purpose, BLM and BLMGLU enyzmatically synthesized were labeled with 131I, quality control studies were done and the incorporation yields of 131I-BLM and 131I-BLMGLU on these cell lines were measured. Quality-control studies showed that the radiolabeling yields were obtained as 95% and 90% for 131I-BLM and 131I-BLMGLU, respectively. Also, as a result of the cell culture studies, it was found that 131I-BLM and 131I-BLMGLU had higher incorporation on PC-3 cells than that of other cell lines. In addition to this, it was reported that the incorporation yield of 131I-BLMGLU was higher than that 131I-BLM. At the end of the study, cytotoxicities of BLM and BLMGLU on PC-3 cancerous cell line were inspected and fluorescent images of BLM and BLMGLU were taken on PC-3 cells by using fluorescein isothiocyanate. In conclusion, cell culture studies demonstrated that the incorporation values of 131I-BLMGLU on the four cell lines were about five to six times higher than 131I-BLM. Radiolabeled glucuronide derivatives can be used in cancer therapy and tumor imaging, depending on the properties of radioiodine for the β-glucuronidase-rich tissues because glucuronidation leads to rapid and higher incorporation on adenocarcinoma cells.Keywords
This publication has 28 references indexed in Scilit:
- Preliminary tests of the radiopharmaceutical potential of N-(2,6-diisopropylphenyl)-N’-(4-pyridyl)-perylene-3,4,9,10-tetracarboxylic diimide radiolabeled with 131IJournal of Radioanalytical and Nuclear Chemistry, 2007
- Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymesCancer Gene Therapy, 2006
- Regulation of Telomerase Activity in Rat Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2002
- Approach to Hodgkin's lymphoma in the new millenniumHematological Oncology, 2001
- Radiolabeled peptides in diagnosis and therapySeminars in Nuclear Medicine, 2001
- Early-stage testis cancerCurrent Treatment Options in Oncology, 2001
- Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neckCancer, 2001
- Non-Hodgkin’s Lymphoma: Pathogenesis, Clinical Presentation, and Treatment2001
- Induction of Telomerase Activity in Fibroblasts from Bleomycin-Injured LungsAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Expression and function of β-glucuronidase in pancreatic cancer: potential role in drug targetingNaunyn-Schmiedeberg's Archives of Pharmacology, 2000